Patent · US Active

Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives

US8377456B2 · kind B2 · utility

2Cited by
40References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 27, 2011
Grant dateFeb 19, 2013
Priority date—
Expiry dateSep 27, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D209/88
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present specification discloses tetrahydroindolone derivatives or analogues and methods for treating cognitive/attention deficit disorders using such tetrahydroindolone derivatives and analogues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.